Daiichi Sankyo
Maria Rubinacci is a seasoned professional in clinical operations and medical affairs, currently serving as the Director of Global Medical Affairs Oncology-Clinical Operations at Daiichi Sankyo, Inc. since June 2019, after holding the position of Associate Director in the same department. Prior experience includes managerial and operational roles at Prometic Biotherapeutics, Inc., ICON plc, and Aptiv Solutions, where responsibilities encompassed project planning, budgeting, contract management, and regulatory compliance across various clinical phases. Maria's expertise is further complemented by a strong research background with institutions such as Northwestern University and Policlinico di Messina, coupled with formal education in Pharmaceutical Biotechnology, Bioethics, and Biotechnology from prestigious universities.
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.